Icon Radiation Oncologist A/Prof David Pryor recently appeared live on the Icon Cancer Centre Facebook page, where he answered questions about prostate cancer and radiation therapy treatment for prostate cancer during COVID-19. A/Prof Pryor was joined by Icon Group Medical Director Dr Ian Irving.
Throughout the video, A/Prof Pryor answered a variety of questions from our patients, including:
- 2.15 – What is Icon doing to protect patients from contracting COVID-19 when they visit a centre for radiation therapy treatment?
- 4.18 – If I am currently completing a course of radiation therapy treatment, should I continue my treatment during COVID-19?
- 5.45 – I’m concerned about COVID-19 and putting myself at risk every time I leave the house. Should I delay regular healthcare (including PSA testing) until the end of the COVID-19 pandemic?
- 7.44 – What are the common signs and symptoms of prostate cancer? When should someone seek medical attention?
- 9.45 – What are the different treatment options used to treat prostate cancer?
- 15.45 – What percentage of patients fall into the category of active surveillance as opposed to requiring treatment for prostate cancer?
- 17.59 – What does radiation therapy involve for prostate cancer treatment? What is the difference between brachytherapy and external beam radiation therapy treatments?
- 23.51 – How long does a course of radiation therapy treatment for prostate cancer take?
- 24.32 – Why do patients normally receive radiation therapy treatment during the week as opposed to weekends?
- 26.06 – What are the side effects of radiation therapy for prostate cancer treatment?
- 29.36 – How is prostate cancer treated if the cancer has spread beyond the prostate to nearby tissues, lymph nodes or other organs of the body?
- 31.49 – Are anti-androgens a possible treatment option to protect me from contracting COVID-19?